Suppr超能文献

《甲状腺细胞病理学报告的贝塞斯达系统》中对甲状腺乳头状癌非侵袭性滤泡变体重新分类对恶性肿瘤风险的影响

Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology.

作者信息

Faquin William C, Wong Lawrence Q, Afrogheh Amir H, Ali Syed Z, Bishop Justin A, Bongiovanni Massimo, Pusztaszeri Marc P, VandenBussche Christopher J, Gourmaud Jolanta, Vaickus Louis J, Baloch Zubair W

机构信息

Massachusetts General Hospital, Boston, Massachusetts.

Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

Cancer Cytopathol. 2016 Mar;124(3):181-7. doi: 10.1002/cncy.21631. Epub 2015 Oct 12.

Abstract

BACKGROUND

Recent discussions have focused on redefining noninvasive follicular variant of papillary thyroid carcinoma (NI-FVPTC) as a neoplasm rather than a carcinoma. This study assesses the potential impact of such a reclassification on the implied risk of malignancy (ROM) for the diagnostic categories of The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).

METHODS

The study consisted of consecutive fine-needle aspiration biopsy (FNAB) cases collected between January 1, 2013 and June 30, 2014 from 5 academic institutions. Demographic information, cytology diagnoses, and surgical pathology follow-up were recorded. The ROM was calculated with and without NI-FVPTC and was presented as a range: all cases (ie, overall risk of malignancy [OROM]) versus those with surgical follow-up only.

RESULTS

The FNAB cohort consisted of 6943 thyroid nodules representing 5179 women and 1409 men with an average age of 54 years (range, 9-94 years). The combined average ROM and OROM for the diagnostic categories of TBSRTC were as follows: nondiagnostic, 4.4% to 25.3%; benign, 0.9% to 9.3%; atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS), 12.1% to 31.2%; follicular neoplasm (FN), 21.8% to 33.2%; suspicious for malignancy (SM), 62.1% to 82.6%; and malignant, 75.9% to 99.1%. The impact of reclassifying NI-FVPTC on the ROM and OROM was most pronounced and statistically significant in the 3 indeterminate categories: the AUS/FLUS category had a decrease of 5.2% to 13.6%, the FN category had a decrease of 9.9% to 15.1%, and the SM category had a decrease of 17.6% to 23.4% (P < .05), whereas the benign and malignant categories had decreases of 0.3% to 3.5% and 2.5% to 3.3%, respectfully. The trend of the effect on the ROM and OROM was similar for all 5 institutions.

CONCLUSIONS

The results from this multi-institutional cohort indicate that the reclassification of NI-FVPTC will have a significant impact on the ROM for the 3 indeterminate categories of TBSRTC.

摘要

背景

最近的讨论集中在将甲状腺乳头状癌的非侵袭性滤泡变体(NI-FVPTC)重新定义为一种肿瘤而非癌。本研究评估了这种重新分类对甲状腺细胞病理学报告贝塞斯达系统(TBSRTC)诊断类别中隐含恶性风险(ROM)的潜在影响。

方法

该研究包括2013年1月1日至2014年6月30日期间从5家学术机构收集的连续细针穿刺活检(FNAB)病例。记录人口统计学信息、细胞学诊断和手术病理随访情况。计算有和没有NI-FVPTC时的ROM,并以范围表示:所有病例(即总体恶性风险[OROM])与仅接受手术随访的病例。

结果

FNAB队列包括6943个甲状腺结节,代表5179名女性和1409名男性,平均年龄54岁(范围9 - 94岁)。TBSRTC诊断类别的综合平均ROM和OROM如下:无法诊断,4.4%至25.3%;良性,0.9%至9.3%;意义不明确的非典型性/意义不明确的滤泡性病变(AUS/FLUS),12.1%至31.2%;滤泡性肿瘤(FN),21.8%至33.2%;可疑恶性(SM),62.1%至82.6%;恶性,75.9%至99.1%。将NI-FVPTC重新分类对ROM和OROM的影响在3个不确定类别中最为显著且具有统计学意义:AUS/FLUS类别下降了5.2%至13.6%,FN类别下降了9.9%至15.1%,SM类别下降了17.6%至23.4%(P <.05),而良性和恶性类别分别下降了0.3%至3.5%和2.5%至3.3%。所有5家机构对ROM和OROM的影响趋势相似。

结论

这个多机构队列的结果表明,NI-FVPTC的重新分类将对TBSRTC的3个不确定类别中的ROM产生重大影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验